The biotech sector in 2025 presents a landscape brimming with both opportunities and challenges. The industry is being shaped ...

The Trump administration is bringing new instability to a sector already grappling with a shaky market as well as threats ...

We hoped industry layoffs would relent in 2024 ... So, here we are, launching our fourth edition of Fierce Biotech's layoff tracker. As always, if you know of a layoff occurring at a biotech ...

Stay ahead in 2025 with the latest biotech deals. Discover key collaborations, M&A, and strategic moves shaping the ...

The healthcare industry is set for growth due to advancements in targeted treatments and personalized care and the rapid ...

Driven by rapid innovations and the integration of modern technologies, the biotech sector is experiencing robust growth.

Invest in SPDR S&P Biotech ETF (XBI) for long-term growth potential and diverse, equal-weighted portfolio in the biotech ...

Despite continued underperformance in 2024, the biotech sector enters 2025 with a brighter outlook driven by groundbreaking ...

The UK biotech sector raised £3.5 billion in equity financing last year amid challenges, according to a BIA report.

Biotech has a big footprint in Massachusetts, and according to a 2023 report, women make up less than 6% of leadership roles in the industry. We asked some women who are in those positions on how ...